CytoSorbents Corp. (CTSO)
5.565
+1.04
(+23.12%)
USD |
NASDAQ |
Nov 18, 16:00
5.18
-0.38
(-6.92%)
After-Hours: 20:00
CytoSorbents Net Income (Quarterly) : -1.834M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.834M |
| June 30, 2026 | -4.417M |
| March 31, 2026 | -5.129M |
| December 31, 2025 | -5.497M |
| September 30, 2025 | -3.17M |
| June 30, 2025 | 1.947M |
| March 31, 2025 | -1.478M |
| December 31, 2024 | -7.884M |
| September 30, 2024 | -2.768M |
| June 30, 2024 | -4.294M |
| March 31, 2024 | -6.089M |
| December 31, 2023 | -6.135M |
| September 30, 2023 | -9.194M |
| June 30, 2023 | -6.153M |
| March 31, 2023 | -7.326M |
| December 31, 2022 | -0.7661M |
| September 30, 2022 | -12.20M |
| June 30, 2022 | -10.88M |
| March 31, 2022 | -8.966M |
| December 31, 2021 | -9.307M |
| September 30, 2021 | -6.406M |
| June 30, 2021 | -4.678M |
| March 31, 2021 | -4.168M |
| December 31, 2020 | -0.6777M |
| September 30, 2020 | -0.8397M |
| Date | Value |
|---|---|
| June 30, 2020 | -2.867M |
| March 31, 2020 | -3.453M |
| December 31, 2019 | -3.949M |
| September 30, 2019 | -6.885M |
| June 30, 2019 | -3.547M |
| March 31, 2019 | -4.884M |
| December 31, 2018 | -5.403M |
| September 30, 2018 | -3.005M |
| June 30, 2018 | -5.821M |
| March 31, 2018 | -2.982M |
| December 31, 2017 | -3.147M |
| September 30, 2017 | -2.054M |
| June 30, 2017 | -1.735M |
| March 31, 2017 | -1.525M |
| December 31, 2016 | -4.906M |
| September 30, 2016 | -2.188M |
| June 30, 2016 | -3.005M |
| March 31, 2016 | -1.836M |
| December 31, 2015 | -2.002M |
| September 30, 2015 | -2.847M |
| June 30, 2015 | 1.434M |
| March 31, 2015 | -4.717M |
| December 31, 2014 | -4.995M |
| September 30, 2014 | -1.498M |
| June 30, 2014 | -1.854M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
| AtriCure, Inc. | 4.064M |
| Baxter International, Inc. | 298.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.728M |
| Total Expenses (Quarterly) | 11.56M |
| EPS Diluted (Quarterly) | -0.5828 |
| Enterprise Value | 42.90M |
| Gross Profit Margin (Quarterly) | 75.33% |
| Profit Margin (Quarterly) | -18.85% |
| Earnings Yield | -96.59% |
| Normalized Earnings Yield | -89.47 |